These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3078190)

  • 21. Efficacy and tolerance of enteric-coated erythromycin base (Ery-Max) administered twice or four times daily in patients with acute bronchitis.
    Pekkanen PS; Josefsson K
    J Int Med Res; 1983; 11(5):285-8. PubMed ID: 6642069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The interrelation of autonomic homeostasis and the broncho-obstructive syndrome in patients with chronic bronchitis and the effect of broncholytic therapy with sal'tos].
    Sokolov AV; Iakushina MS; Iakushin SS
    Ter Arkh; 1996; 68(11):70-2. PubMed ID: 9045388
    [No Abstract]   [Full Text] [Related]  

  • 23. An in-vitro comparison of controlled release aminophylline tablets: Phyllocontin Continus and Pecram.
    Smart JD; Barnes MS; Norris MJ
    J Pharm Pharmacol; 1992 Jul; 44(7):623-5. PubMed ID: 1357150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S; Raina RK; Samotra K; Gupta KL
    Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminophylline suppositories and sustained-release tablets compared in bronchospasm.
    Ross AE
    Practitioner; 1981 Jul; 225(1357):1061-2. PubMed ID: 7031630
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of an oral aminophylline compound with protracted activity on respiratory resistance and blood gases in obstructive respiratory diseases (author's transl)].
    Dorow P
    Arzneimittelforschung; 1978; 28(5):853-6. PubMed ID: 373776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of chronic bronchitis. Results of a field study with Brondiletten retard].
    d'Ottilie H; Dornbusch R; Adams HJ
    Ther Ggw; 1976 Dec; 115(12):2104-16. PubMed ID: 798346
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative bioavailability of slow release dicbfenac (Voveran SR) with enteric coated tablet and internationally used Voltaren retard.
    Kumar PD
    J Assoc Physicians India; 1992 Jul; 40(7):483. PubMed ID: 1484038
    [No Abstract]   [Full Text] [Related]  

  • 30. [The pharmacodynamics of theophylline (euphylline)].
    Tsoĭ AN; Bogovskiĭ BP; Saprygina TV; Kniazev RM; Titova EV; Kukes VG
    Ter Arkh; 1993; 65(8):36-40. PubMed ID: 8211799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled release salbutamol tablets versus aminophylline in the control of reversible airways obstruction.
    Higenbottam TW; Khan MA; Williams DO; Mikhail JR; Peake MD; Hughes J
    J Int Med Res; 1989; 17(5):435-41. PubMed ID: 2680678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of intravenous aminophylline and salbutamol in the treatment of severe bronchospasm.
    Beswick K; Davies J; Davey AJ
    Practitioner; 1975 Apr; 214(1282):561-566. PubMed ID: 1096127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nebetol in the treatment of bronchial asthma and chronic obstructive bronchitis].
    Popovac D; Spasić P; Vukcević G
    Plucne Bolesti; 1985; 37(1-2):106-9. PubMed ID: 3906721
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients].
    Cegla UH
    Prax Klin Pneumol; 1988 Sep; 42(9):715-21. PubMed ID: 3141915
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of berotec and atropine on the ventilatory function and blood gases in patients with chronic bronchitis].
    Kurgan J
    Pol Tyg Lek; 1983 Jan; 38(5):149-51. PubMed ID: 6408625
    [No Abstract]   [Full Text] [Related]  

  • 36. An evaluation of a controlled-release aminophylline tablet (Phyllocontin Continus) as a concomitant therapy in patients receiving salbutamol.
    Boyd G; Clark CJ
    J Int Med Res; 1979; 7 Suppl 1():34-5. PubMed ID: 374162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison between depot terbutaline tablets and ordinary terbutaline tablets].
    Pedersen B; Iversen B
    Ugeskr Laeger; 1987 Jan; 149(3):162-5. PubMed ID: 3547972
    [No Abstract]   [Full Text] [Related]  

  • 38. FAILURE OF U.S.P. DISINTEGRATION TEST TO ASSESS PHYSIOLOGIC AVAILABILITY OF ENTERIC COATED TABLETS.
    LEVY G; HOLLISTER LE
    N Y State J Med; 1964 Dec; 64():3002-5. PubMed ID: 14224243
    [No Abstract]   [Full Text] [Related]  

  • 39. [Stability and clinical effectiveness of aminophylline in glucose and isotonic NaCl solution].
    Pietruszewska E; Wrońska J; Droszcz W
    Pol Tyg Lek; 1983 Mar; 38(11):337-9. PubMed ID: 6634479
    [No Abstract]   [Full Text] [Related]  

  • 40. [Place of ketocef in treating chronic bronchitis and its effect on the patient's body].
    Molotkov VN; Chernushenko EF; Maliuk VM; Zhukovskiĭ LI; Bil'ko IP
    Ter Arkh; 1983; 55(3):71-7. PubMed ID: 6344304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.